Expert Ratings for Arrowhead Pharma
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 11 analysts have published their opinion on Arrowhead Pharma (NASDAQ:ARWR) stock. The average price target is $62.45, implying an upside from the current price of $35.61. The average price target has increased by 42.74% over the past month.
June 30, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Arrowhead Pharma, with an average price target of $62.45, indicating potential growth from the current price of $35.61.
The bullish outlook from analysts indicates a positive sentiment towards Arrowhead Pharma. The average price target, which is significantly higher than the current price, suggests potential growth for the stock. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100